Optimal cut-off value and clinical usefulness of adherence starts with knowledge-12 (ASK-12) in asthmatic patients taking inhaled corticosteroid
Masaya Takemura (Nagoya, Japan), Masaya Takemura, Masayuki Nishio, Kensuke Fukumitsu, Norihisa Takeda, Hiroya Ichikawa, Takamitsu Asano, Hisatoshi Hijikata, Yoshihiro Kanemitsu, Takehiro Uemura, Osamu Takakuwa, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Atsushi Nakamura, Kosho Yoshikawa, Akio Niimi
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Masaya Takemura (Nagoya, Japan), Masaya Takemura, Masayuki Nishio, Kensuke Fukumitsu, Norihisa Takeda, Hiroya Ichikawa, Takamitsu Asano, Hisatoshi Hijikata, Yoshihiro Kanemitsu, Takehiro Uemura, Osamu Takakuwa, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Atsushi Nakamura, Kosho Yoshikawa, Akio Niimi. Optimal cut-off value and clinical usefulness of adherence starts with knowledge-12 (ASK-12) in asthmatic patients taking inhaled corticosteroid. Eur Respir J 2016; 48: Suppl. 60, 5016
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: